These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 7253807

  • 1. Pharmacological difference of L-dopa, apomorphine, and bromocriptine against metoclopramide.
    Fang VS.
    Life Sci; 1981 May 11; 28(19):2143-9. PubMed ID: 7253807
    [No Abstract] [Full Text] [Related]

  • 2. Neuroendocrine aspects in monitoring of dopaminergic drugs in man.
    Hietala J, Koulu M, Scheinin M, Syvälahti E.
    Methods Find Exp Clin Pharmacol; 1985 Aug 11; 7(8):451-4. PubMed ID: 3935892
    [Abstract] [Full Text] [Related]

  • 3. Metaclopramide and prolactin secretion in man: effects of pretreatment with L-dopa and 2-bromo-alpha-ergocryptine (CB-154).
    Delitala G, Masala A, Alagna S, Devilla L.
    IRCS J Med Sci; 1975 Jun 11; 3(6):274. PubMed ID: 1165172
    [No Abstract] [Full Text] [Related]

  • 4. Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.
    Johnson AM, Loew DM, Vigouret JM.
    Br J Pharmacol; 1976 Jan 11; 56(1):59-68. PubMed ID: 943193
    [Abstract] [Full Text] [Related]

  • 5. Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.
    Carey RM, Thorner MO, Ortt EM.
    J Clin Invest; 1980 Jul 11; 66(1):10-8. PubMed ID: 7400305
    [Abstract] [Full Text] [Related]

  • 6. Suppression of prolactin by dopamine agonists in schizophrenics and controls.
    Rotrosen J, Angrist B, Clark C, Gershon S, Halpers FS, Sachar EJ.
    Am J Psychiatry; 1978 Aug 11; 135(8):949-51. PubMed ID: 665840
    [Abstract] [Full Text] [Related]

  • 7. Prolactin response to electroconvulsive shock in anesthetized rats.
    Golan D, Aharoni A, Halbreich U.
    J Psychiatr Res; 1993 Aug 11; 27(3):235-40. PubMed ID: 8295155
    [Abstract] [Full Text] [Related]

  • 8. [Response of hGH to insulin hypoglycemia and to bromocriptine before and after the administration of L-dopa in primary hypothyroidism].
    Campino C, Pumarino H, Michelsen H, Piraino P, Generini G, Bruggendieck B.
    Rev Med Chil; 1985 Apr 11; 113(4):296-300. PubMed ID: 3915142
    [No Abstract] [Full Text] [Related]

  • 9. Dopaminergic regulation of prolactin secretion in the hyperprolactinemic syndrome.
    Ayalon D, Eckstein N, Avidan S, Eshel A, L'Hermite M, Caufriez A, Spitz I, Zylber-Haran E.
    Gynecol Obstet Invest; 1983 Apr 11; 16(2):97-106. PubMed ID: 6413305
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of cimetidine-induced hyperprolactinaemia by pretreatment with levodopa or bromocriptine.
    Rolandi E, Masturzo P, Barreca T.
    Clin Endocrinol (Oxf); 1979 Jan 11; 10(1):93-5. PubMed ID: 436308
    [Abstract] [Full Text] [Related]

  • 11. The role of dopamine in the formation of gastric ulcers in rats.
    Sikirić P, Geber J, Suchanek E, Ivanović D, Gjuris V, Aleksić J, Reić P, Marović A.
    Eur J Pharmacol; 1985 May 28; 112(1):127-8. PubMed ID: 4018137
    [Abstract] [Full Text] [Related]

  • 12. Central dopaminergic and serotoninergic systems in the regulation of adrenal tyrosine hydroxylase.
    Quik M, Sourkes TL.
    J Neurochem; 1977 Jan 28; 28(1):137-47. PubMed ID: 13151
    [No Abstract] [Full Text] [Related]

  • 13. The effect of dopaminergic drugs on pituitary hormone release in normal subjects.
    Sekso M, Solter M, Banovac K, Vizner B, Petek M.
    Acta Med Iugosl; 1977 Jan 28; 31(4):321-32. PubMed ID: 596235
    [No Abstract] [Full Text] [Related]

  • 14. Suppression of MPTP-induced dopaminergic neurotoxicity in mice by nomifensine and L-DOPA.
    Melamed E, Rosenthal J, Globus M, Cohen O, Uzzan A.
    Brain Res; 1985 Sep 09; 342(2):401-4. PubMed ID: 3876139
    [Abstract] [Full Text] [Related]

  • 15. Presynaptic neuron and postsynaptic dopamine receptor function in long term treatment of Parkinson's disease: a neuroendocrine study.
    Agnoli A, Ruggieri S, Baldassarre M, Rocco A, Del Roscio S, D'Urso R, Mearelli S, Falaschi P, Frajese G.
    Prog Clin Biol Res; 1980 Sep 09; 39():215-24. PubMed ID: 6773067
    [No Abstract] [Full Text] [Related]

  • 16. Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin.
    Foord SM, Peters JR, Dieguez C, Scanlon MF, Hall R.
    Endocrinology; 1983 May 09; 112(5):1567-77. PubMed ID: 6832061
    [Abstract] [Full Text] [Related]

  • 17. Quipazine-metoclopramide inhibition of CB-154-induced prolactin suppression in rats: neurotransmitter-metabolite correlations.
    Lipham LB, Porter JK, Norred WP, Booth NH, Robbins JD.
    Proc Soc Exp Biol Med; 1987 Mar 09; 184(3):250-5. PubMed ID: 2881309
    [Abstract] [Full Text] [Related]

  • 18. Prolactin secretion by metoclopramide in man.
    Judd SJ, Lazarus L, Smythe G.
    J Clin Endocrinol Metab; 1976 Aug 09; 43(2):313-7. PubMed ID: 7571
    [Abstract] [Full Text] [Related]

  • 19. Studies on the inhibitory effect of apomorphine and bromocryptine on basal and TRH induced level of TSH and PRL in hypothyroid rats under pentobarbiturate anesthesia.
    Langer P, Mess B, Földes O, Ruzsás C, Brozmanová H, Straussová K, Gschwendtová K.
    Exp Clin Endocrinol; 1984 May 09; 83(3):269-74. PubMed ID: 6432565
    [Abstract] [Full Text] [Related]

  • 20. No effects of l-dopa and bromocriptine on psychophysiological parameters of human selective attention.
    Oranje B, Gispen-de Wied CC, Westenberg HG, Kemner C, Verbaten MN, Kahn RS.
    J Psychopharmacol; 2006 Nov 09; 20(6):789-98. PubMed ID: 16478755
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.